Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors
1 other identifier
observational
754
1 country
31
Brief Summary
To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Longer than P75 for all trials
31 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2018
CompletedFirst Posted
Study publicly available on registry
October 24, 2018
CompletedStudy Start
First participant enrolled
April 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2024
CompletedMarch 18, 2025
March 1, 2025
5.5 years
October 23, 2018
March 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
HRQoL (Health Related Quality of Life)
To longitudinally and quantitatively describe the HRQoL of a diverse nation-wide cohort of sibling pediatric Hematopoietic Stem Cell (HSC) donors (Peripheral Blood Stem Cell or Bone Marrow) and to compare their HRQoL to that of (1) healthy non-donor sibling from the same family, (2) siblings of children with similar diseases who receive alternate treatments (e.g., unrelated cord blood transplants), and (3) healthy age, gender, and race/ethnicity-matched controls.
1 year
Secondary Outcomes (2)
1 year post-donation
1 year
Donor characteristics
1 year
Study Arms (6)
Sibling pediatric donors
Donors who are donating to a sibling
Sibling recipients and caregivers
Recipients who are receiving a transplant from a sibling
Non-donor sibling
From the donor-recipient families
Non-donor siblings
Of patients receiving unrelated transplants
Healthy comparison
A matched sample
Parents
Parent/caregiver of study participating donor.
Eligibility Criteria
Pediatric donors, their recipients and caregivers, non-donor siblings from the donor-recipient families, and non-donor siblings of patients receiving unrelated transplants.
You may qualify if:
- Participants must fall into one of the following categories:
- Donor between the age of 5 and 17 who is donating to a sibling
- Parent/caregiver of study participating donor
- Recipient sibling aged 5 to 17 of study participating donor
- Any of the donor's non-donor/non-recipient siblings between 5 and 17
- Any child between 5 and 17 with a brother or sister (also between 5 and 17) receiving a transplant from an unrelated source
- Be willing and able to provide signed informed consent:
- Adults must give consent for their children's and, if applicable, their own participation
- Assent will be obtained in accordance with guidelines at the participant's transplant institution
- Be willing and able to respond to psychological assessment questions
- Must be the donor's first donation
- Recipient must consent to the CIBMTR research database
You may not qualify if:
- For families with pediatric donors aged 5 to 17, at minimum, the donor child and/or one parent must consent/assent to participation. If that minimum is not met, the family will be excluded
- Donor or non-donor siblings who do not live in the same household as the recipient at lease half of the time
- Unable to consent/assent or complete a phone interview in English
- Parents may consent/assent in Spanish
- No access to a telephone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (31)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
City of Hope
Duarte, California, 91010, United States
Loma Linda University
Loma Linda, California, 92354, United States
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
Rady Children's Hospital San Diego
San Diego, California, 92123, United States
University of California San Francisco Medical Center
San Francisco, California, 94143, United States
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20910, United States
Niklaus Children's Hospital
Miami, Florida, 33155, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
University of Louisville Hospital - James Brown Cancer Center
Louisville, Kentucky, 40202, United States
Children's Hospital of New Orleans/LSUHSC
New Orleans, Louisiana, 70118, United States
NIH/NCI
Bethesda, Maryland, 20892, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Spectrum Health
Grand Rapids, Michigan, 49503, United States
The Children's Mercy Hospitals and Clinics
Kansas City, Missouri, 64108, United States
St. Louis Children's Hospital
St Louis, Missouri, 63110, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
Westchester Medical Center
New York, New York, 10595, United States
University of North Carolina Hospitals
Chapel Hill, North Carolina, 27599, United States
Duke University Medical Center
Durham, North Carolina, 27705, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
Children's Health (formerly Children's Medical Center Dallas)
Dallas, Texas, 75235, United States
Methodist Healthcare System of San Antonio/Texas Transplant Institute
San Antonio, Texas, 78229, United States
University of Utah Blood and Marrow Transplant Program - Pediatrics
Salt Lake City, Utah, 84112, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Galen Switzer, Ph.D
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2018
First Posted
October 24, 2018
Study Start
April 3, 2019
Primary Completion
October 8, 2024
Study Completion
October 8, 2024
Last Updated
March 18, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share